Viberzi Prior Authorization with Quantity Limit Criteria - Medicare Part D

Medicare Utilization Management Policy
Version Date: January 1, 2025

Prior Authorization Criteria for Approval

Viberzi will be approved when ALL of the following are met:

  1. The patient has a diagnosis of irritable bowel syndrome with diarrhea (IBS-D)
    AND

  2. The patient does NOT have any FDA labeled contraindications to the requested medication
    AND

  3. ONE of the following:

    1. The requested quantity (dose) does NOT exceed the program quantity limit
      OR

    2. ALL of the following:

      1. The requested quantity (dose) is greater than the program quantity limit
        AND
      2. The requested quantity (dose) cannot be achieved with a lower quantity of a higher strength that does not exceed the program quantity limit
        AND
      3. The prescriber has provided information in support of therapy with a higher dose for the requested indication

Length of Approval: 12 months